MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced the launch of the Defiance Daily Target 2X Short LLY ETF (Ticker: LLYZ). This fund provides investors with amplified 2X …

… analysis shared with Fierce Pharma Marketing. The one newcomer on … Otsuka’s Rexulti and Eli Lilly and Boehringer Ingelheim’s … the brands directed their ads toward major networks, with … one psoriatic arthritis) Biggest-ticket ad: “Break Away: Relentless Weed” …

… seen in consumer advertising. At its foundation, the chief marketing officer role … brand officer at Eli Lilly, refers to this concept as the head of marketing … be doing this marketing. We believe in this campaign,’” Cronin says. That …

EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The Crohn’s disease (CD) treatment landscape is undergoing a radical transformation as newer mechanisms of action (MOAs), particularly IL-23 inhibitors and JAK inhibitors, continue displace long-standing …

… an interview with Fierce Pharma Marketing. "So the first … Up Tomorrow" campaign';s star, Pat (Eli Lilly) As a voiceover … online, social and display ads. To up its chances of … . Indeed, along with tracking brand awareness and prescription count, she …

Eli Lilly is promoting its Alzheimer’s medication Kisunla with a national ad campaign … s Light Up Tomorrow campaign rolled out earlier this … trivializing the disease. The campaign — which was crafted by … Additionally, Steele said the campaign’s core message is …

… administration could pursue limiting DTC ads." Jennifer Bragg Partner, Latham … of time in any advertisement or promotional communication.” A ban isn’t … approach DTC marketing in new ways. Several companies, including Pfizer, Eli Lilly and …

… Tirzepatide is sold under the brand name Mounjaro.Belonging to a … . Story continues below this ad Another important finding of the … Story continues below this ad While there is a link … well. Importantly, the competitor of Eli Lilly’s tirzepatide — Novo Nordisk’ …

Eli Lilly’s Alzheimer’s disease (AD) drug donanemab has been … . Donanemab, approved under the brand name Kisunla in countries including … in the brain associated with AD. Patrik Jonsson, executive vice … will lead to a prompt marketing authorisation by the EC, …

… WNBA All-Star weekend and Eli Lilly is lacing up to raise … brand officer at Lilly, the company intends to use its sponsorships … s Hands campaign, which featured a 60-second television ad that … plans to continue its sports marketing venture, given the venue …